MRSA Eye Infections on the Rise, Treatment Lagging.
While the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), particularly the community-acquired form, in ophthalmic infections continues to rise, the scope of the problem is being underrecognized and treatment is often inappropriate, researchers warned here at the American Academy of Ophthalmology 2011 Annual Meeting. These conclusions come from a multicenter 6-year study of nearly 400 patients by researchers from the Kaiser Permanente Medical Group in Union City, California. The results were presented by coinvestigator Jordon Piluek, MD, from Stanford University in Palo Alto, California.